Movement Alert｜GENSCRIPT B-1K Intraday Rise 3.15% in Regular Trading, Latest FMR LLC Stake Increase Supports Sentiment

Market Focus10-22

On October 22, GENSCRIPT B-1K posted an Intraday Rise of 3.15% in Regular Trading, trading at HK$35.4 with turnover of HK$31.82 million.

The most recent catalyst in public disclosures was FMR LLC's latest stake increase. Exchange data showed that on October 15, FMR LLC increased its holding by about 4.74 million shares at an average price of HK$32.7813 per share, involving roughly HK$155 million. After the transaction, its holding rose to about 187 million shares, or 8.18%.

This followed a series of earlier institutional purchases, while the company had also disclosed that Legend Biotech's core product CARVYKTI generated about US$710 million in net trade sales in the quarter ended September 30, with cumulative sales of about US$1.964 billion in the first three quarters. The combination of continued institutional accumulation and commercial sales growth has helped underpin market attention on the name.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment